Adanate 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 
  • ||||||||||  ADA-011 / Adanate
    Trial termination, Monotherapy, Checkpoint inhibition:  A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Jan 28, 2025   
    P1,  N=46, Terminated, 
    Active, not recruiting --> Terminated; Internal company decision (non-safety related)
  • ||||||||||  ADA-011 / Adanate
    Enrollment closed, Enrollment change, Trial completion date, Monotherapy, Checkpoint inhibition:  A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Sep 19, 2024   
    P1,  N=45, Active, not recruiting, 
    Active, not recruiting --> Terminated; Internal company decision (non-safety related) Recruiting --> Active, not recruiting | N=90 --> 45 | Trial completion date: Dec 2025 --> Dec 2024
  • ||||||||||  ADA-011 / Adanate
    Enrollment open, Monotherapy, Checkpoint inhibition:  A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  Jan 9, 2023   
    P1,  N=90, Recruiting, 
    Recruiting --> Active, not recruiting | N=90 --> 45 | Trial completion date: Dec 2025 --> Dec 2024 Not yet recruiting --> Recruiting